Inventor · disambiguated record
Douglas J. Jolly
Also filed as: JOLLY DOUGLAS · JOLLY DOUGLAS J
53 granted patents·22 pending applications·3,170 citations·filing 1993–2021
99Inventor score
Top patents by PatentIndex Score
75 records- 0199US5814482AEukaryotic layered vector initiation systemsFiled 1996·Granted Sep 29, 1998·536 cites·25 claims
- 0298US6015686AEukaryotic layered vector initiation systemsVIAGENE INC·Filed 1995·Granted Jan 18, 2000·253 cites·20 claims
- 0398US5843723AAlphavirus vector constructsCHIRON CORP·Filed 1996·Granted Dec 1, 1998·327 cites·47 claims
- 0498US5789245AAlphavirus structural protein expression cassettesCHIRON CORP·Filed 1996·Granted Aug 4, 1998·345 cites·29 claims
- 0597US7977091B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Jul 12, 2011·38 cites·4 claims
- 0696US6015694AMethod for stimulating an immune response utilizing recombinant alphavirus particlesCHIRON CORP·Filed 1997·Granted Jan 18, 2000·228 cites·11 claims
- 0795US5716826ARecombinant retrovirusesVIAGENE INC·Filed 1993·Granted Feb 10, 1998·116 cites·8 claims
- 0895US5716613ARecombinant retrovirusesVIAGENE INC·Filed 1995·Granted Feb 10, 1998·120 cites·7 claims
- 0994US5591624ARetroviral packaging cell linesVIAGENE INC·Filed 1993·Granted Jan 7, 1997·217 cites·9 claims
- 1093US7070994B2Packaging cellsOXFORD BIOMEDICA LTD·Filed 2002·Granted Jul 4, 2006·46 cites·5 claims
- 1192US5851529ARecombinant retrovirusesFiled 1995·Granted Dec 22, 1998·85 cites·16 claims
- 1291US6730297B1Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disordersCHIRON CORP·Filed 2000·Granted May 4, 2004·41 cites·13 claims
- 1389US5691177ARecombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agentFiled 1995·Granted Nov 25, 1997·62 cites·24 claims
- 1488US7572628B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Aug 11, 2009·9 cites·34 claims
- 1588US5888502ARecombinant retrovirusesFiled 1995·Granted Mar 30, 1999·57 cites·72 claims
- 1688US5817491AVSV G pseusdotyped retroviral vectorsUNIV CALIFORNIA·Filed 1994·Granted Oct 6, 1998·135 cites·22 claims
- 1787US8829173B2Recombinant vectorsGRUBER HARRY E·Filed 2011·Granted Sep 9, 2014·8 cites·33 claims
- 1886US9669049B2Compositions comprising gamma retrovirus vectors and methods of treating proliferative disordersGRUBER HARRY E·Filed 2011·Granted Jun 6, 2017·6 cites·27 claims
- 1986US6818439B1Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disordersCHIRON CORP·Filed 1997·Granted Nov 16, 2004·92 cites·20 claims
- 2086US5716832APackaging cellsVIAGENE INC·Filed 1995·Granted Feb 10, 1998·63 cites·11 claims
- 2186US5693522AAnti-cancer immunotherapeuticsVIAGENE INC·Filed 1995·Granted Dec 2, 1997·70 cites·20 claims
- 2285US8722867B2Gene therapy vectors and cytosine deaminasesGRUBER HARRY E·Filed 2011·Granted May 13, 2014·7 cites·44 claims
- 2384US9320738B2Formulations of 5-fluorocytosine and uses thereofGRUBER HARRY E·Filed 2009·Granted Apr 26, 2016·5 cites·68 claims
- 2481US9732326B2Recombinant vectorsTOCAGEN INC·Filed 2014·Granted Aug 15, 2017·3 cites·24 claims
- 2580US11230719B2Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2015·Granted Jan 25, 2022·2 cites·11 claims
- 2679US10035983B2Gene therapy vectors and cytosine deaminasesTOCAGEN INC·Filed 2014·Granted Jul 31, 2018·3 cites·6 claims
- 2779US5997859AMethod for treating a metastatic carcinoma using a conditionally lethal geneCHIRON CORP·Filed 1995·Granted Dec 7, 1999·46 cites·19 claims
- 2878US11279949B2Recombinant vectors comprising 2A peptideDENOVO BIOPHARMA LLC·Filed 2016·Granted Mar 22, 2022·3 cites·22 claims
- 2977US11065311B2Retroviral vector with mini-promoter cassetteDENOVO BIOPHARMA LLC·Filed 2013·Granted Jul 20, 2021·2 cites·40 claims
- 3076US11191764B2Formulations of 5-fluorocytosine and uses thereofDENOVO BIOPHARMA LLC·Filed 2019·Granted Dec 7, 2021·0 cites·18 claims
- 3175US5662896ACompositions and methods for cancer immunotherapyVIAGENE INC·Filed 1993·Granted Sep 2, 1997·36 cites·4 claims
- 3275US2020239858A1Recombinant vectorsTOCAGEN INC·Filed 2019·Application pending·0 cites
- 3374US9889133B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2016·Granted Feb 13, 2018·1 cites·18 claims
- 3474US9663834B2Retrovirus detectionJOLLY DOUGLAS J·Filed 2011·Granted May 30, 2017·1 cites·30 claims
- 3573US9642921B2Cancer combination therapy and recombinant vectorsTOCAGEN INC·Filed 2013·Granted May 9, 2017·1 cites·14 claims
- 3673US6855549B1Methods and compositions for increasing the infectivity of gene transfer vectorsUNIV IOWA RES FOUND·Filed 1999·Granted Feb 15, 2005·34 cites·34 claims
- 3772US5856185AMethod for making reflection defective retroviral vectors for infecting human cellsCHIRON CORP·Filed 1995·Granted Jan 5, 1999·32 cites·18 claims
- 3870US7034010B2Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disordersUNIV IOWA RES FOUND·Filed 2003·Granted Apr 25, 2006·2 cites·5 claims
- 3968US5830458AMethod for destroying a diseased human cellFiled 1995·Granted Nov 3, 1998·19 cites·38 claims
- 4065US6297048B1Hepatitis therapeuticsCHIRON CORP·Filed 1995·Granted Oct 2, 2001·29 cites·7 claims
- 4165US6133029AReplication defective viral vectors for infecting human cellsCHIRON CORP·Filed 1995·Granted Oct 17, 2000·21 cites·8 claims
- 4264US6241982B1Method for treating brain cancer with a conditionally lethal geneCHIRON CORP·Filed 1995·Granted Jun 5, 2001·12 cites·34 claims
- 4364US2022195460A1Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 4463US10449194B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2018·Granted Oct 22, 2019·0 cites·13 claims
- 4562US10407666B2Recombinant vectorsTOCAGEN INC·Filed 2017·Granted Sep 10, 2019·0 cites·10 claims
- 4662US2021361691A1Enhanced cancer treatment and monitoring using recombinant vectorsDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 4761US2004029278A1Eukaryotic layered vector initiation systemsCHIRON CORP·Filed 2002·Application pending·0 cites
- 4859US11060112B2Producer cells for replication competent retroviral vectorsDENOVO BIOPHARMA LLC·Filed 2019·Granted Jul 13, 2021·0 cites·12 claims
- 4957US2018021365A1Enhanced cancer treatment and monitoring using recombinant vectorsTOCAGEN INC·Filed 2017·Application pending·0 cites
- 5056US5698446AMethods and compositions for inhibiting production of replication competent virusCHIRON CORP·Filed 1994·Granted Dec 16, 1997·17 cites·25 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Douglas J. Jolly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →